Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to FFO of $0.34 per share a year ago.
Sabra Health Care REIT: Turning The Corner
Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.
Sabra Health Care REIT, Inc. (SBRA) Q2 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2024 Earnings Conference Call August 8, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank Austin Wurschmidt - KeyBanc Capital Markets Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Securities John Pawlowski - Wells Fargo Rich Anderson - Wedbush Securities Michael Stroyeck - Green Street Advisors, LLC Alec Feygin - Baird Equity Research Operator Good day, everyone. My name is Christina, and I will be your conference operator today.
Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Sabra Healthcare (SBRA) Q2 FFO and Revenues Top Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to FFO of $0.34 per share a year ago.
Sabra (SBRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Sabra (SBRA) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Sabra Health Care REIT: 2 Catalysts That Should Ignite Solid Growth
High interest rates have pressured businesses, but lower rates are expected to provide relief soon, particularly for REITs. Sabra Health Care REIT is poised to benefit from lower interest rates and an aging population. Despite lower occupancy levels, SBRA is expected to outperform peers with solid growth of 4.75% over the next 3 years.
Natixis Advisors L.P. Purchases 1,696 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)
Natixis Advisors L.P. lifted its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 8.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,270 shares of the real estate investment trust’s stock after buying an additional 1,696 shares during the period. Natixis Advisors L.P.’s holdings in Sabra Health Care REIT were worth $317,000 at the end of the most recent reporting period. Other institutional investors and hedge funds also recently modified their holdings of the company. Signaturefd LLC lifted its position in shares of Sabra Health Care REIT by 45.2% during the 3rd quarter. Signaturefd LLC now owns 2,610 shares of the real estate investment trust’s stock valued at $36,000 after buying an additional 813 shares during the last quarter. Retirement Systems of Alabama raised its stake in shares of Sabra Health Care REIT by 0.3% during the 4th quarter. Retirement Systems of Alabama now owns 289,592 shares of the real estate investment trust’s stock valued at $4,132,000 after purchasing an additional 890 shares during the period. Arizona State Retirement System lifted its holdings in Sabra Health Care REIT by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 65,828 shares of the real estate investment trust’s stock worth $918,000 after purchasing an additional 900 shares in the last quarter. Van ECK Associates Corp boosted its stake in Sabra Health Care REIT by 4.3% in the 3rd quarter. Van ECK Associates Corp now owns 27,111 shares of the real estate investment trust’s stock worth $378,000 after purchasing an additional 1,124 shares during the period. Finally, Tennessee Valley Asset Management Partners purchased a new position in Sabra Health Care REIT during the 4th quarter valued at about $25,000. 99.40% of the stock is owned by hedge funds and other institutional investors. Sabra Health Care REIT Trading Down 1.0 % NASDAQ SBRA opened at $14.33 on Monday. The stock has a 50-day moving average of $14.22 and a 200-day moving average of $14.07. The company has a current ratio of 4.33, a quick ratio of 4.33 and a debt-to-equity ratio of 0.89. Sabra Health Care REIT, Inc. has a 1-year low of $10.30 and a 1-year high of $14.92. The firm has a market cap of $3.32 billion, a PE ratio of 71.65, a price-to-earnings-growth ratio of 5.15 and a beta of 1.17. Sabra Health Care REIT Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Monday, May 20th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.37%. The ex-dividend date is Friday, May 17th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%. Analysts Set New Price Targets A number of analysts have recently issued reports on SBRA shares. Wedbush reiterated an “outperform” rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Deutsche Bank Aktiengesellschaft began coverage on shares of Sabra Health Care REIT in a research report on Tuesday, January 30th. They set a “buy” rating and a $21.00 target price for the company. Finally, Scotiabank increased their price target on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 15th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $15.71. View Our Latest Research Report on SBRA About Sabra Health Care REIT (Free Report) As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. See Also Five stocks we like better than Sabra Health Care REIT Are Penny Stocks a Good Fit for Your Portfolio? MarketBeat Week in Review – 5/13 – 5/17 The How And Why of Investing in Oil Stocks Take-Two Interactive Software Offers 2nd Chance for Investors How to invest in marijuana stocks in 7 steps Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report).
